Cédric van Marcke

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study

Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa et al. · Journal of Clinical Oncology · 2023 · 87 citations · Full text

Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma

Rachel Galot, Cédric van Marcke, Raphaël Helaers et al. · Oral Oncology · 2020 · 65 citations · Full text

Mutational Profiling, Oncology, Tumor Heterogeneity +9

Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

Natasha Honoré, Cédric van Marcke, Rachel Galot et al. · Annals of Oncology · 2023 · 46 citations · Full text

Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03

Afshin Dowlati, Anne C. Chiang, Andrés Cervantes et al. · Journal of Thoracic Oncology · 2025 · 33 citations · Full text

Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer

Mieke Van Bockstal, Fanchon Noël, Yves Guiot et al. · Annals of Diagnostic Pathology · 2020 · 31 citations · Full text

Breast Oncology, Predictive Markers, Medicine +9